Literature DB >> 31402266

Risk prediction models for intensive care unit readmission: A systematic review of methodology and applicability.

Nader Markazi-Moghaddam1, Mohammad Fathi2, Azra Ramezankhani3.   

Abstract

OBJECTIVE: We conducted a systematic review of primary models to predict intensive care unit (ICU) readmission. REVIEW
METHODS: We searched MEDLINE, PubMed, Scopus, and Embase for studies on the development of ICU readmission prediction models that are published until January 2017. Data were extracted on the source of data, participants, outcomes, candidate predictors, sample size, missing data, methods for model development, and measures of model performance and model evaluation. The quality and applicability of the included studies were assessed using the CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies.
RESULTS: We identified five studies describing the development of the primary prediction models of ICU readmission. Studies ranged in size from 343 to 704,963 patients with the mean age of 58.0-68.9 years. The proportion of readmission ranged from 2.5% to 9.6%. The discriminative ability of prediction models measured by area under the receiver operating characteristic curve was 0.66-0.81. None of the studies performed external validations. The quality scores ranged from 42 to 54 out of 62, and the applicability scores from 24 to 32 out of 38.
CONCLUSION: We identified five prediction models for ICU readmission. However, owing to the numerous methodological and reporting deficiencies in the included studies, physicians using these models should interpret the predictions with precautions until an external validation study shows the acceptable level of calibration and accuracy of these models.
Copyright © 2019 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intensive care units; Prediction; Readmission; Review

Mesh:

Year:  2019        PMID: 31402266     DOI: 10.1016/j.aucc.2019.05.005

Source DB:  PubMed          Journal:  Aust Crit Care        ISSN: 1036-7314            Impact factor:   2.737


  6 in total

1.  Current Trends in Readmission Prediction: An Overview of Approaches.

Authors:  Kareen Teo; Ching Wai Yong; Joon Huang Chuah; Yan Chai Hum; Yee Kai Tee; Kaijian Xia; Khin Wee Lai
Journal:  Arab J Sci Eng       Date:  2021-08-16       Impact factor: 2.807

2.  The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.

Authors:  M Fathi; F Taghizadeh; H Mojtahedi; S Zargar Balaye Jame; N Markazi Moghaddam
Journal:  Rev Neurol (Paris)       Date:  2021-09-13       Impact factor: 4.313

3.  Impact of respiratory therapists-driven assess-and-treat protocol on unplanned adult neurovascular ICU readmissions: a quality improvement initiative.

Authors:  Fajun Wang; Amitha Avasarala; Nizari Pandya; Karan Panchal; Darby Scarantine; Allan David; Jeniffer Bozogan; Jennifer Arendas; Julia Maseth; Megan Lowman; Samantha Zych; Jonathan Bishop; Firas Abdulmajeed
Journal:  BMJ Open Qual       Date:  2022-05

4.  A Simple Scoring Tool to Predict Medical Intensive Care Unit Readmissions Based on Both Patient and Process Factors.

Authors:  Nirav Haribhakti; Pallak Agarwal; Julia Vida; Pamela Panahon; Farsha Rizwan; Sarah Orfanos; Jonathan Stoll; Saqib Baig; Javier Cabrera; John B Kostis; Cande V Ananth; William J Kostis; Anthony T Scardella
Journal:  J Gen Intern Med       Date:  2021-01-22       Impact factor: 5.128

5.  Development and validation of an interpretable 3 day intensive care unit readmission prediction model using explainable boosting machines.

Authors:  Stefan Hegselmann; Christian Ertmer; Thomas Volkert; Antje Gottschalk; Martin Dugas; Julian Varghese
Journal:  Front Med (Lausanne)       Date:  2022-08-23

6.  Identifying patients at risk of unplanned re-hospitalisation using statewide electronic health records.

Authors:  David Rolls; Justin Boyle; Aida Brankovic; Philippa Niven; Sankalp Khanna
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.